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TegumentThe tegument of Schistosoma mansoni plays an integral role in host–parasite interactions, particularly
during the transition from the free-living cercariae to the intra-mammalian schistosomula stages. This
developmental period is characterised by the transition from a trilaminate surface to a heptalaminate
tegument that plays key roles in immune evasion, nutrition and excretion. Proteins exposed at the sur-
face membranes of newly transformed schistosomula are therefore thought to be prime targets for the
development of new vaccines and drugs for schistosomiasis. Using a combination of tegumental labelling
and high-throughput quantitative proteomics, more than 450 proteins were identified on the apical
membrane of S. mansoni schistosomula, of which 200 had significantly regulated expression profiles at
different stages of schistosomula development in vitro, including glucose transporters, sterols, heat shock
proteins, antioxidant enzymes and peptidases. Current vaccine antigens were identified on the apical
membrane (Sm-TSP-1, calpain) or sub-tegumental (Sm-TSP-2, Sm29) fractions of the schistosomula, dis-
playing localisation patterns that, in some cases, differ from that in the adult stage fluke. This work pro-
vides the first known in-depth proteomic analysis of the surface-exposed proteins in the schistosomula
tegument, and some of the proteins identified are clear targets for the generation of new vaccines and
drugs against schistosomiasis.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Schistosomiasis is one of the most important neglected tropical
diseases affecting more than 200 million people worldwide
(Gryseels et al., 2006; Colley et al., 2014), particularly in developing
and tropical regions. Three main species of schistosomes are of
major medical relevance: Schistosoma mansoni and Schistosoma
japonicum, the eggs of which induce hepatosplenic inflammation
and liver fibrosis when trapped in the portal system (Gryseels
et al., 2006), and Schistosoma haematobiumwhich is linked to blad-
der cancer in chronically infected people (James et al., 1974;
Schwartz, 1981; Mayer and Fried, 2007). Despite the widespread
use of the anthelmintic drug Praziquantel for the last 20 years in
mass drug administration programs, this parasitic infection still
causes a loss of 1.53 million disability-adjusted life years (DALYs)
and up to 280,000 deaths annually in sub-Saharan Africa alone(van der Werf et al., 2003; King et al., 2005; Gryseels et al., 2006;
Steinmann et al., 2006). Indeed, the DALYs attributed to schistoso-
miasis may be far greater than initially appreciated due to recent
awareness of the morbidity associated with infections that were
traditionally classified as ‘‘asymptomatic’’ (King, 2015).
Schistosoma mansoni presents a complex life cycle that involves
a freshwater snail where the ciliated miracidium undergoes asex-
ual replication through mother and daughter sporocyst stages,
eventually shedding thousands of cercariae (Colley et al., 2014).
The cercariae exit the snail into freshwater approximately 4–
6 weeks after infection and quickly penetrate the skin of the
human host. Once in the skin, cercariae shed their tail and trans-
form into schistosomula, which slowly migrate through the skin
before entering the blood capillaries en route to the lungs and ulti-
mately into the portal system where they feed on blood and
mature into dioecious adult worms (Miller and Wilson, 1980;
Gryseels et al., 2006). Schistosome adult flukes live for 3–10 years
in their definitive human hosts, mainly due to their ability to avoid
immune-mediated clearance (Kusel et al., 2007). Their unique,
dynamic, tegumental structure and the complex immuno-evasive
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harsh intravascular environment (Pearce and MacDonald, 2002).
The tegument of S. mansoni participates in different processes
such as nutrition, excretion, signal transduction, osmoregulation
and immune evasion and modulation, playing a key role in host–
parasite interactions (Jones et al., 2004; Mulvenna et al., 2010).
The great complexity of this dynamic membrane helps the parasite
to transform from a free-living phase into a parasitic stage that
migrates through distinct environments in the definitive host
(Brink et al., 1977). By replacing its tegumental composition, in just
a few hours, the parasite switches from an immune-sensitive to an
immune-refractory state (Jones et al., 2004). Different studies have
analysed the morphological changes that occur in the outer mem-
brane of S. mansoni during development from cercariae to adult
worms under different conditions. Hockley and McLaren (1971)
described a trilaminate outer membrane in cercariae and a multi-
laminate membrane in adult worms, and then went on to implicate
membrane-bound vacuoles produced by sub-tegumental cells in
the formation of the heptalaminate membrane of juvenile parasites
(Hockley and McLaren, 1973).
The use of in vitro transformed schistosomula was first studied
by Clegg and Smithers (1972), who showed that the growth rate of
schistosomula in vitro was identical to the growth rate in vivo for
at least 12 days. In addition, the morphological changes that occur
in the schistosomula in the first 4 days post-transformation are
similar in parasites isolated from the lungs of mice and in parasites
cultured in media (Samuelson et al., 1980). The similar morpholog-
ical features displayed by in vitro and in vivo transformed schisto-
somula (Brink et al., 1977; Samuelson et al., 1980), opened the
possibility of using manually transformed schistosomula for labo-
ratory research instead of lung schistosomula which are notori-
ously difficult to obtain in large numbers. More recently, gene
expression studies revealed the surprising similarities between
mechanical- and skin-transformed schistosomula, where signifi-
cant differences were detected in the expression of just 38 from
11,000 different genes (Protasio et al., 2013). While the transcrip-
tional changes in the first few days of schistosomula development
in vitro have been characterised (Fitzpatrick et al., 2009; Gobert
et al., 2010), few studies have addressed the proteome of this crit-
ical life cycle stage (De la Torre Escudero et al., 2011; Hong et al.,
2011, 2013), and none have focused on the surface proteome of
the two most important human schistosome species, S. mansoni
and S. haematobium.
The schistosomula stage is critical for sexual maturation and
parasite establishment, and its surface plays an important role in
host–parasite interactions, being the most susceptible target for
vaccines and drugs against Schistosoma spp. (Jones et al., 2004;
Loukas et al., 2007). Using a combination of tegumental labelling
and high-throughput quantitative proteomics techniques we have
identified a number of proteins that are highly expressed on the
tegument of S. mansoni schistosomula at different stages of devel-
opment, and highlight the utility of some of these proteins for the
design of novel therapeutics against this important neglected trop-
ical disease.2. Materials and methods
2.1. Parasite material
Schistosoma mansoni (Puerto Rican strain) -infected
Biomphalaria glabrata snails were provided by the National
Institute of Allergy and Infectious Diseases (NIAID) Schistoso
miasis Resource Center for distribution through BEI Resources,
NIAID, National Institutes of Health (NIH), USA: S. mansoni, Strain
NMRI Exposed B. glabrata, NR-21962. Cercariae were collectedfrom the snails as described previously (Tucker et al., 2013), and
immediately transformed into schistosomula by vortexing fol-
lowed by a Percoll gradient to separate tails from bodies (Colley
and Wikel, 1974; Tucker et al., 2013). Transformed schistosomula
were incubated in Basch medium at 37 C, 5% CO2 (Basch, 1981)
at a density of 30,000 schistosomula in 4 mL of medium for 3 h,
2 days and 5 days. As a control, non-cultured schistosomula were
processed immediately after transformation from cercariae.
2.2. Biotinylation of schistosomula tegument
The method used for tegumental biotinylation is a modified ver-
sion of the method followed by Mulvenna et al. (2010).
Approximately 60,000 schistosomula were used at each time point
studied. The parasites were cultured for defined periods as
described in Section 2.1, washed in Hank’s Buffered Salt Solution
(HBSS; Invitrogen, USA) twice at room temperature (RT) and incu-
bated with 1 mM EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fischer
Scientific, USA) for 30 min at 4 C. Biotin was then removed and
parasites washed three times at RT in RPMI 1640 with free amino
acids (Invitrogen) to quench any remaining biotin. The parasites
were then snap-frozen in liquid nitrogen and kept at 80 C until
further use. Teguments were removed using the freeze/thaw/vor-
tex technique (Roberts et al., 1983), where schistosomula were
slowly thawed on ice, washed in TBS (10 mM Tris/HCl, 0.84%
NaCl, pH 7.4) and incubated for 5 min on ice in 10 mM Tris/HCl,
pH 7.4, before vortexing for five 1 s bursts. The tegumental extract
was pelleted at 1000g for 30 min and solubilised three times in
200 ll of solubilising solution containing 0.1% (w/v) SDS, 1.0% (v/
v) Triton X-100 in 40 mM Tris, pH 7.4 with pelleting at 15,000g
between each wash. The washes were combined and incubated
with 240 ll of streptavidin-agarose beads (GE Healthcare, UK) for
2 h at RT with gentle head-over-head mixing. After pelleting the
beads, the supernatant was collected and proteins that were not
bound to streptavidin beads were retained as the ‘‘unbound’’ frac-
tion. Proteins bound to streptavidin were eluted by incubating the
beads three times with 300 ll of 2% SDS for 10 min at 95 C fol-
lowed by vortexing for 2 min. Proteins eluted from streptavidin
in SDS were retained as ‘‘biotinylated’’ proteins.
2.3. Immunofluorescence and microscopy analysis
For microscopy purposes, parasites were biotinylated with
1 mM EZ-Link Sulfo-NHS-SS-Biotin as described in Section 2.2.
Parasites were then washed three times in HBSS, incubated with
streptavidin-FITC for 30 min at RT and washed twice more with
HBSS. Negative control parasites were not labelled with biotin
and were instead incubated with just streptavidin-FITC.
Biotinylated parasites that were not subjected to streptavidin-
FITC were also analysed to detect autofluorescence from the biotin
label. Samples were visualised using a Zeiss AxioImager M2
ApoTome fluorescence microscope (Zeiss, Germany) equipped with
an AxioCam MRn at 60 magnification.
To visualise the extent of biotin internalisation in schistoso-
mula, biotinylated and unbound (control) parasites were fixed in
4% paraformaldehyde in 0.1 phosphate buffer, pH 7.4, for 30 min
at RT followed by thorough washing in PBS. Samples were embed-
ded in paraffin, cut and stained with streptavidin-Alexa-555 and
counterstained with DAPI before visualisation with a LSM 780 con-
focal microscope (Zeiss) at 100 magnification.
2.4. Protein digestion and iTRAQ labelling
Two biological samples for each time point were processed and
analysed as follows: iTRAQ labelling, reduction, alkylation and
digestion was performed on biotinylated and unbound samples
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35 lg of protein from each sample was denatured with 2% SDS,
reduced with 50 mM Tris-(2-carboxyethyl)-phosphine (TCEP) at
60 C for 1 h, and cysteine residues were alkylated with 10 mM
methyl methanethiosulfate (MMTS) solution at RT for 10 min.
Proteins were digested using 1 lg of trypsin (Sigma–Aldrich,
USA) at 37 C for 16 h, and each sample was labelled with different
iTRAQ reagents having distinct isotopic compositions. A HiTrap SP
HP column (GE Healthcare) was used to remove excess iTRAQ label
according to the manufacturer’s instructions and desalting and
cleanup of samples were performed prior to electrofocusing using
and a Sep-Pak C18 cartridge (Waters, USA).
2.5. OFFGEL electrophoresis
Labelled peptides were separated based on pI using a 3100
OFFGEL Fractionator (Agilent Technologies, USA) with a 24 well
setup as per the manufacturer’s protocol. Briefly, 24 cm long, 3–
10 linear pH range IPG gel strips (GE Healthcare) were rehydrated
with IPG Strip Rehydration Solution for 15 min. The tryptic pep-
tides were diluted in 3.6 ml of peptide-focusing buffer and 150 ll
was loaded in each well. Samples were focused with a maximum
current of 50 lA until 50 kVh was reached, and peptide fractions
were harvested and each well rinsed with 150 ll of a solution of
water/methanol/formic acid (49%/50%/1%) for 15 min. Solutions
were pooled with their corresponding peptide fraction and all frac-
tions were evaporated using a vacuum concentrator. Prior to mass
spectral analysis, samples were desalted using ZipTip (Millipore,
USA) according to the manufacturer’s protocol, followed by cen-
trifugation under vacuum.
2.6. Reverse-Phase (RP) LC–MS/MS analysis
Fractions recovered from OFFGEL electrophoresis were recon-
stituted in 10 ll of 5% formic acid. Six microlitres of sample was
injected onto a 50 mm 300 lm C18 trap column (Agilent
Technologies) and the samples were desalted on the trap column
for 5 min at 30 lL/min using 0.1% formic acid (aqueous). Peptides
were then eluted onto an analytical nano HPLC column
(150 mm  75 lm 300SBC18, 3.5 lm, Agilent Technologies) at a
flow rate of 300 nL/min and separated using a 35 min gradient of
1–40% buffer B (90/10 acetonitrile/0.1% formic acid) followed by
a steeper gradient from 40–80% buffer B for 5 min. The mass spec-
trometer operated in information-dependent acquisition mode
(IDA), in which a 1 s TOF MS scan from 350–1400 m/z was per-
formed, and for product ion ms/ms 80–1400 m/z ions observed
in the TOF-MS scan exceeding a threshold of 100 counts and a
charge state of +2 to +5 were set to trigger the acquisition of pro-
duct ion. Analyst 1.6.1 (AB SCIEX) software was used for data
acquisition and analysis.
2.7. Database searching and bioinformatic analysis
All searches for the biotinylated andunbound fractionswere per-
formedsimilarly against thepeptide sequencespredicted fromthe S.
mansoni genome data (Berriman et al., 2009) using MASCOT search
engine v4.0 (Matrix-Science).Mascot searcheswere donewith tryp-
tic specificity, allowing a mass tolerance of ±0.5 Da and two missed
cleavages. Methionine oxidation, carbamidomethylation and iTRAQ
standard modifications were used as variable modifications. The
results from the Mascot searches were validated using the
X!Tandem search engine with the program Scaffold Q+(version
Scaffold_4.2.1) (Searle, 2010). Peptide and protein identifications
were accepted if they could be established at greater than 95% and
99% probability, respectively, as specified by the Peptide
Prophet algorithm (Keller et al., 2002), and contained at least twoidentified peptides (proteins) (Nesvizhskii et al., 2003). Proteins
containing similar peptides that could not be differentiated based
on MS/MS analysis were grouped to satisfy the principles of parsi-
mony. A false discovery rate (FDR) of <0.2%and<0.3% for thebiotiny-
lated and unbound fractions, respectively, was calculated using
protein identifications validated by the Scaffold Q+ program.
Scaffold Q+ was used to quantify the isobaric tag peptide and
protein identifications. Channels were corrected in all samples
according to the algorithm described in i-Tracker (Shadforth
et al., 2005) and acquired intensities in the experiment were glob-
ally normalised across all acquisition runs. Individual quantitative
samples were normalised within each acquisition run, and intensi-
ties for each peptide identification were normalised within the
assigned proteins. The reference channels were normalised to pro-
duce a 1:1-fold change. All normalisation calculations were per-
formed using medians to multiplicatively normalise data.
Differentially expressed proteins were determined using Kruskal–
Wallis Test analysis and results expressed in log2 ratios. Only pro-
teins with a P value <0.05 and a significant log2 fold-change >0.6 or
<0.6 (for upregulated and downregulated proteins, respectively)
were taken into consideration for further analysis.
Protein identifications were assigned to subcellular locations
using a combination of UniLoc (http://bioapp.iis.sinica.edu.tw/
UniLoc/index.html) and literature searches. Blast2Go (Conesa
et al., 2005) was used to classify proteins according to Gene
Ontology (GO) categories, and protein family (Pfam) analysis was
performed using HMMER v3.1b1 (http://hmmer.org/). Putative sig-
nal peptides and transmembrane domain(s) were predicted using
the programs SignalP (Emanuelsson et al., 2007) and TMHMM
(Krogh et al., 2001), respectively. Heatmaps representing the differ-
entially expressed proteins were generated in R using ggplot2
(Ginestet, 2011) and clustering was performed using Euclidean
distances.3. Results
3.1. Biotin binds specifically to the outer membrane of schistosomula
The use of different sulfo-biotin derivatives for the isolation of
tegumental proteins in schistosome adults has been validated in
the past (Braschi andWilson, 2006; Mulvenna et al., 2010). To anal-
yse the suitability and the extent of biotin incorporation in schisto-
somula, manually transformed, live parasites were biotinylated on
ice using EZ-Link Sulfo-NHS-SS-Biotin and subjected to immunoflu-
orescence analysis. Biotinylated parasites were incubated with
streptavidin-FITC and a clear and intense labelling was detected
over the entire tegument of the schistosomula (Fig. 1A). Control par-
asites (unbound) did not show any non-specific labelling of strepta-
vidin-FITC (Fig. 1B) and biotinylated parasites that were not
incubated with streptavidin-FITC did not show any auto-fluores-
cence (data not shown). To analyse the distribution of biotin on
the schistosomula tegument and rule out the potential labelling of
the gastrodermis and other internal structures, biotinylated para-
sites were fixed and subjected to immunohistochemical analysis.
Due to themorphological differences of the tegument in the schisto-
somula at different stages, we analysed the tegumental biotinyla-
tion in young (3 h) and 5 day schistosomula. Biotin was not
observed in the internal organs and gastrodermis of the parasite,
thereby excluding its ingestion during incubation, and confirming
that only tegumental proteins were labelled (Fig. 1C and D).3.2. Time-course quantitative analysis of tegumental proteins
Tegument of S. mansoni schistosomula was labelled with biotin,
extracted following established methods, labelled with iTRAQ
Fig. 1. Immunofluorescence micrograph showing surface biotinylation of Schistosoma mansoni schistosomula. Transformed schistosomula were incubated with biotin and
probed with streptavidin-FITC (A). Streptavidin-FITC did not bind to the tegument of non-biotinylated schistosomula (B). The short-chain thiol-cleavable biotin was
incorporated only into the outer surface of the tegument in 3 h (C) and 5 day (d) schistosomula (D); there was no apparent labelling of the gastrodermis in any of the
parasites.
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logical replicates from each time point were analysed and a total
of 28,217 spectra were acquired and used to assign unique pep-
tides and unique proteins, leading to the identification of 463 pro-
teins in the biotinylated samples (Supplementary Table S1). The
quantification analysis was performed using Scaffold Q+, and only
proteins with a P value <0.05 and a log2 fold-change >0.6 or <0.6
(for upregulated and downregulated proteins, respectively) were
taken into consideration for further analysis. A total of 200 proteins
had significantly dysregulated expression profiles in at least one of
the time points studied (Supplementary Table S2); of these, 22 pro-
teins contained a signal peptide and 28 had a transmembrane
domain (Supplementary Table S3). A total of 894 proteins were
identified in the unbound fraction (proteins not labelled with bio-
tin and thus present in the schistosomula tegument cytoplasm and
sub-tegumental tissues), of which 377 underwent significant
expression changes during the experiment (Supplementary
Table S4).The significantly differentially expressed tegumental proteins
were subjected to a GO-enrichment analysis using Blast2GO
(Conesa et al., 2005), grouped into 10 GO annotation categories
and plotted in a clustered heatmap (Fig. 2). Clustering was per-
formed based on protein expression patterns using Euclidean dis-
tances and dendrograms were reordered based on mean values.
A clear set of proteins was significantly upregulated at all time
points studied, while the majority of proteins were downregulated
compared with newly transformed schistosomula (Supplementary
Table S3). Proteins assigned to peptidase and kinase activities
were, in general, significantly downregulated on the tegument of
schistosomula over time, whereas heat shock proteins were gener-
ally upregulated as the parasites developed (Fig. 2). The signifi-
cantly dysregulated proteins were also classified into six groups
according to their predicted subcellular location using UniLoc
and literature searches (Fig. 2). The majority of extracellular pro-
teins were downregulated over time, while the cytoskeletal,
Fig. 2. Clustered heatmap of differentially expressed tegumental proteins in Schistosoma mansoni schistosomula. The relative expression of schistosomula proteins at 3 h, 2
and 5 days (d) was compared with freshly transformed schistosomula. Proteins were grouped into 10 different Gene Ontology (GO) categories and six location categories
based on GO annotation and predicted locations from UniLoc and literature searches. Clustering was performed using Euclidean distances.
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tern during schistosomula development (Fig. 2).
A more in-depth analysis based on the subcellular location
showed some differences in expression profiles of proteins upreg-
ulated on the schistosomula surface over time. While more cyto-
plasmic and nuclear proteins were upregulated on the tegument
at 5 days post-transformation compared with earlier time points,
the number of upregulated membrane-associated proteins
decreased from 3 h to 2 days post-transformation (Fig. 3A). The
numbers of upregulated proteins (compared with newly trans-
formed parasites) associated with cytoskeleton, mitochondria
and other organelles remained similar throughout the experiment
(Fig. 3A). The number of significantly upregulated proteins at each
time point was studied and compared with the other time points to
show the degree of tegumental protein turnover. Interestingly,
more significantly upregulated proteins were found at day 5 (76
proteins) compared with day 2 (67) or 3 h (57) schistosomula,
and from these, a total of 41 proteins were common at all time
points (Fig. 3B; Supplementary Table S5). Seven proteins were
uniquely found at 3 h post-transformation and 14 proteins at
5 days post-transformation, while only two unique proteins were
present on the schistosomula tegument at 2 days post-transforma-
tion. The analysis of cytoplasmic/nuclear proteins and membrane-
associated proteins also showed some differences. Whereas eight
upregulated cytoplasmic/nuclear proteins were uniquely found at
5 days post-transformation, only one protein was found at 3 h,
and none at 2 days (Fig. 3B). In addition, four membrane-associated proteins were upregulated exclusively in 3 h schistoso-
mula and another four proteins were exclusively upregulated in
5 day schistosomula, whereas no unique proteins were found at
2 days post-transformation (Fig. 3B).
The significantly dysregulated proteins from every studied time
point were also subjected to a Pfam analysis. The 10 most repre-
sented protein domains from each time point are shown in Fig. 4.
Interestingly, proteins with Redoxin, Thioredoxin-like domains
and AhpC/TSA domains were upregulated during schistosomula
growth but, in contrast, significantly upregulated proteins with
an Annexin domain were only found at 3 h and 2 days post-
transformation.
4. Discussion
The tegument of schistosomes plays an important role in differ-
ent processes such as parasite development, nutrition and immune
evasion and modulation (Jones et al., 2004; Skelly et al., 2014). As
the parasite infects its definitive host, it undergoes different mor-
phological changes to adapt to an intra-mammalian environment,
including the switch from a trilaminate outer membrane in cer-
cariae and newly transformed schistosomula to a heptalaminate
membrane in adult worms (Hockley and McLaren, 1971). The hep-
talaminate tegument consists of an invaginated plasma membrane
overlain by the membranocalyx, a lipid bilayer formed when the
membrane of multilaminate vesicles trafficking from the tegumen-
tary cell bodies fuses with the apical plasma membrane that
Fig. 3. Subcellular location of biotinylated proteins from the Schistosoma mansoni tegument. Bar graph showing the abundance of proteins assigned to five different
subcellular locations at 3 h, 2 and 5 days (d) (A). Venn diagrams of common proteins upregulated at the different time points by subcellular location (B).
Fig. 4. Protein family (Pfam) analysis of biotinylated proteins from the Schistosoma mansoni tegument. Bar graph summarising 10 most abundant Pfam in the significantly
upregulated proteins from the tegument of S. mansoni schistosomula. Proteins with Redoxin, Thioredoxin-like domains and AhpC/TSA domains (in bold) were upregulated
during schistosomula growth but, in contrast, significantly upregulated proteins with an Annexin domain (in bold) were only found at 3 h and 2 days post-transformation.
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Hockley and McLaren, 1973; Wilson and Barnes, 1977; Braschi
and Wilson, 2006). The first few days of life for a schistosomulum
in the mammalian host present a critical target for the develop-
ment of vaccine-mediated protection (McManus and Loukas,
2008; Wilson and Coulson, 2009), since the parasite adopts animmune-refractory state as it rapidly matures on its sojourn
through the lungs (Jones et al., 2004). Different studies have eluci-
dated some of the genes and proteins involved in cercaria-schisto-
somula transformation and in schistosomula development;
however, these mechanisms are not yet fully understood. The use
of mechanically transformed schistosomula can help in the
Table 1
Suggested proteins for target purposes. Proteins were analysed according to tegumental expression and regulation, predicted function and/or previous studies. Log2 fold change
expression values for each protein at 3 h, 2 days (d) and 5 days post-transformation schistosomula compared to newly transformed schistosomula. Proteins identified in other
biotinylation studies are denoted as 1 (Braschi and Wilson, 2006) and 2 (Mulvenna et al., 2010). Protein expression levels were compared with gene expression levels obtained by
Gobert et al. (2010). Only expression levels from 3 h to 5 day schistosomula were compared, as controls used by Gobert et al. (2010) were cercariae instead of freshly transformed
schistosomula.
Predicted
Function
Identified protein Accession
Number
Location 3 h 2 d 5 d Identified Transcriptomic
comparisona
Binding Annexin Smp_074140 Cytoskeleton 0.6 0.2 0.5 1, 2 Downregulated
Dynamin Smp_044920 Cytoskeleton 2.4 2.6 1.2 – ?
T-complex protein 1 subunit alpha (tcp-1-alpha) Smp_017360 Cytoskeleton 0.7 2.1 2.3 – –
Chaperonin containing t-complex protein 1 Smp_004990 Cytosol/Nucleus 2.6 3.5 3.4 – Up/downregulated
Guanine nucleotide-binding protein beta 1 Smp_094480 Cytosol/Nucleus 3.2 2.8 3.8 – –
Histone H2A Smp_031720 Cytosol/Nucleus 1.1 1.6 3 – Upregulated
Histone H3 Smp_082240 Cytosol/Nucleus 2.3 2.7 4.8 – Upregulated
Histone H4 Smp_053290 Cytosol/Nucleus 1.7 1.7 3.4 – Upregulated
P30 dbc protein Smp_056360.5 Cytosol/Nucleus 1.4 3.8 3.7 – –
Proteasome regulatory subunit-related Smp_058650 Cytosol/Nucleus 1 1.6 2.1 – Upregulated
Histone h2b Smp_108390 Cytosol/Nucleus 0.2 0.4 3.4 – –
Ribosomal protein S9 Smp_119920 Cytosol/Nucleus 0.4 0.7 1.2 – –
60S acidic ribosomal protein P0 Smp_009690.1 Cytosol/Nucleus 0.1 0.1 0.6 – Upregulated
14-3-3 protein Smp_009760 Cytosol/Nucleus 0.4 1.3 1.1 2 Upregulated
E1b-55kd-associated protein Smp_062720.5 Cytosol/Nucleus 0.6 0.3 1.5 – Upregulated
Clathrin heavy chain Smp_154420.1 Membrane
associated
1.3 2.1 1.7 – Upregulated
Programmed cell death protein Smp_136640 Membrane
associated
0.7 1.4 1.1 – Upregulated
Trimeric g-protein alpha o subunit Smp_016630.1 Membrane
associated
2.1 1.6 1 – Upregulated
Ankyrin 2,3/unc44 Smp_139110 Membrane
associated
0.1 0.5 0.6 – –
Receptor for activated Protein Kinase C Smp_102040.1 Membrane
associated
0.1 1.1 1.5 – Upregulated
Low-density lipoprotein receptor (ldl) Smp_020550 Membrane
associated
0 0 2 – Upregulated
Succinyl-coa synthetase beta chain Smp_167330 Mitochondria 3 2.6 0.9 – Upregulated
Calreticulin autoantigen homologue precursor Smp_030370 Unknown/Other 0.4 0.9 1.2 – –
Cyclophilin B Smp_040790 Unknown/Other 0 0.6 1 – Upregulated
Heat Shock
Protein
Heat shock protein 70 Smp_106930.1 Cytosol/Nucleus 1 2.1 2.3 1, 2 Downregulated
Heat shock protein (hsp16) Smp_148530 Cytosol/Nucleus 1.6 3.8 4.9 –
Heat shock protein Smp_072330.1 Cytosol/Nucleus 0 2.1 2.1 –
Heat shock protein (hsp60) Smp_008545 Mitochondria 0.9 1.6 1.2 – ?
Heat shock protein 70 (hsp70) Smp_049550 Unknown/Other 0.8 3.4 0 1, 2 Downregulated
Kinase Integrin-linked protein kinase 2 (ilk-2) Smp_079760.1 Membrane
associated
0.9 0.5 1.1 – Upregulated
Other
enzymatic
Glyceraldehyde-3-phosphate dehydrogenase
(gapdh)
Smp_056970.1 Cytoskeleton 0.7 1.2 0.6 1, 2 Downregulated
Thioredoxin peroxidase Smp_059480 Cytosol/Nucleus 2.9 0.4 2.2 2 Upregulated
Adenosylhomocysteinase Smp_028440.1 Cytosol/Nucleus 0.9 0.3 0.7 – Upregulated
Expressed protein Smp_105680.1 Membrane
associated
0.6 1.4 2.7 – –
Protein disulfide-isomerase Smp_056760 Membrane
associated
0.2 0.8 0.8 – Upregulated
Dihydrolipoamide succinyltransferase Smp_104330 Mitochondria 1.3 1.5 1.3 – Upregulated
Protein disulphide-isomerase er-60 precursor
(erp60)
Smp_079770.1 Unknown/Other 1.3 2.7 2.4 – Upregulated
Other/
Unknown
Arp2/3 complex 20 kd subunit Smp_160770.1 Cytoskeleton 0.7 0 0.8 – –
40s ribosomal protein s10 Smp_066890 Cytosol/Nucleus 0.9 1.2 1.7 – –
Universal stress protein Smp_043120 Cytosol/Nucleus 1.4 2.3 3.4 – ?
Expressed protein Smp_099420 Membrane
associated
1.7 2.2 1.9 – –
Glucose transport protein Smp_012440 Membrane
associated
4.2 4.5 4.4 2 Upregulated
Prohibitin Smp_075210.2 Membrane
associated
1.9 2.7 1.8 – –
Prohibitin Smp_075940 Membrane
associated
2 2.5 2 – Upregulated
Prominin (prom) protein Smp_130520.1 Membrane
associated
1.9 2.5 1.5 – Upregulated
Sterol reductase-related Smp_124300 Membrane
associated
4.3 4 4.5 – –
Stomatin-related Smp_072640 Membrane
associated
2.7 3.1 3.5 – –
Venom allergen-like (val) 4 protein Smp_002070 Membrane
associated
2.8 3 4.5 – –
(continued on next page)
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Table 1 (continued)
Predicted
Function
Identified protein Accession
Number
Location 3 h 2 d 5 d Identified Transcriptomic
comparisona
Venom allergen-like (val) 6 protein Smp_124050.4 Membrane
associated
1 0 3.3 – –
Voltage-dependent anion-selective channel Smp_091240.1 Membrane
associated
1.3 1.6 1 1, 2 –
Family M13 non-peptidase homologue (M13
family)
Smp_000755 Membrane
associated
0.6 0.3 0.9 – –
Peptidase Invadolysin (m08 family) Smp_090100 Cytosol/Nucleus 2.2 2.4 0 – –
Invadolysin (m08 family) Smp_090110 Cytosol/Nucleus 2 1.6 4.3 – –
Leucine aminopeptidase (m17 family) Smp_030000 Cytosol/Nucleus 2.3 0.7 0.4 – –
Cercarial elastase (s01 family) Smp_006510 Extracellular 1.3 3.4 0 – Downregulated
Farnesylated-protein converting enzyme 1 (m48
family)
Smp_082620 Membrane
associated
0.6 0.4 0.5 – –
Mitochondrial phosphate carrier protein Smp_083720 Membrane
associated
1.3 0.9 0.4 – –
Mitochondrial processing peptidase beta-subunit
(m16 family)
Smp_009650.1 Mitochondria 0.4 0.6 1.1 – –
Calpain (C02 family) Smp_157500 Membrane
associated
2.2 1 1 1, 2 ?
Structural/
Motor
Myosin-10 (heavy chain-b) (nmmhc-b) Smp_046060.1 Cytoskeleton 2 2.4 1.1 – –
Flotillin-2 Smp_033970 Membrane
associated
1.4 2.2 2.4 – Upregulated
Talin 2 Smp_142630 Membrane
associated
2.1 3.4 3.1 – Upregulated
Tubulin beta chain Smp_079960 Structural/Motor 0 0.1 1.6 2 Downregulated
Transporter Adp, atp carrier protein Smp_079220 Membrane
associated
2.8 2.9 2.5 2 Downregulated
Transferase Conserved hypothetical protein Smp_017450 Cytosol/Nucleus 0.4 2 1.4 –
Glutathione S-transferase 28 kda (GST 28) (GST
class-mu)
Smp_054160 Cytosol/Nucleus 0.6 0.5 0.8 2 Up/downregulated
a Due to difficulties in cross matching the protein codes from the present study with the ones from Gobert et al. (2010), the comparison was made by annotations.
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to their shared morphology and gene expression patterns (Brink
et al., 1977; Samuelson et al., 1980; Protasio et al., 2013); however,
very few studies have analysed the protein composition of the
schistosomula (De la Torre Escudero et al., 2011; Hong et al.,
2011, 2013), and none have specifically focused on the schistoso-
mula tegument of the major human-infecting species. Different
techniques have been applied to the study of the tegumental pro-
teomic composition from the adult stage of different Schistosoma
spp., and the use of biotin for labelling the membrane has proven
to be a valid method to locate surface exposed proteins on the api-
cal membrane of adult parasites (Braschi and Wilson, 2006;
Mulvenna et al., 2010; Zhang et al., 2013). In the present study
we used a short-chain, thiol-cleavable biotin derivative for the
analysis of tegumental proteins from the schistosomula stage of
S. mansoni, and taking advantage of OFFGEL separation techniques
and quantitative mass spectrometry methods, we have identified
and quantified a large number of differentially expressed proteins
on the apical membranes of the parasites. Some of these proteins
are clear targets for the generation of new vaccines and drugs
against schistosomiasis (Table 1).
A total of 463 proteins were identified on the tegument of S.
mansoni schistosomula, of which 200 were significantly regulated
during the experiment. All 463 proteins were also found in the
unbound fraction, which might indicate incomplete affinity purifi-
cation with streptavidin agarose; however, van Balkom et al.
(2005) found the majority of tegumental proteins were also pre-
sent in the body of the adult parasite after the tegument had been
stripped, and other authors attributed this to the sub-tegumental
location of cell bodies beneath the tegument syncytium, whereby
surface proteins are shuttled to the syncytial membranes via com-
plex transport networks (Braschi et al., 2006). From the 36 proteins
identified in a previous study to be present in Schistosoma bovisschistosomula (De la Torre Escudero et al., 2011), 24 (66.7%) were
also identified in our analysis. In addition, six of the proteins iden-
tified in the present study were previously shown to be differen-
tially expressed in S. japonicum schistosomula compared with
adult flukes (Hong et al., 2013). Furthermore, the pattern of up-
and downregulation of proteins in our study agrees with changes
in gene expression profiles from transcriptomic studies (Table 1)
(Gobert et al., 2010).
After a GO-enrichment analysis, the majority of proteins were
assigned ‘‘binding activity’’, which includes proteins involved in
many different biological processes. Interestingly, most of the pro-
teins with putative peptidase activity (73%) were rapidly down-
regulated and only three peptidases were upregulated at least at
one time point throughout the experiment (notably at 3 h or 5 days
post-transformation) (Supplementary Table S3). A cercarial elas-
tase (Smp_006510) underwent a 1.3 and > 3-fold downregulation
at 3 h and 2 days post-transformation, respectively, and was not
detected at 5 days post-transformation. This serine protease has
been described as the major enzyme responsible for skin penetra-
tion by cercariae together with a chymotrypsin-like protease
(Salter et al., 2000). In addition, the downregulated protein
Smp_062080, a serine protease inhibitor, has been found to regu-
late the enzymatic activity of cercarial elastase to minimise host
tissue damage at the site of larval invasion and prevent severe
inflammation (Quezada et al., 2012). Other proteases were
detected in the schistosomula apical membrane, including metal-
loproteases belonging to the Invadolysin (Smp_090100 and
Smp_090110) and Leucine aminopeptidase (Smp_030000) fami-
lies. The Invadolysin Smp_090100 was the first metalloprotease
described in the cercarial secretions (Curwen et al., 2006), and,
together with the Invadolysin Smp_090110, was significantly
downregulated (2.4 and 1.6, respectively) in 3 day old schisto-
somula compared with cercariae (Parker-Manuel et al., 2011).
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Smp_083720, Smp_009650.1) might play roles in the migration
of schistosomula through the dermal and sub-dermal tissues en
route to the vasculature, although dedicated studies are required
to confirm this hypothesis. The GO-enrichment analysis also
revealed five heat shock proteins that were upregulated during
the experiment (Supplementary Table S3). These highly conservedFig. 5. Expansion and annotation of the schistosome tegumental protein turnover hypo
from the tegumentary cell bodies (Wilson and Barnes, 1977; Skelly and Shoemaker, 2001;
tegument changes over time. Proteins represented were selected according to level of dys
MV multilaminate vesicles; HSP, heat shock protein; TSP, tetraspanin; VAL, venom allerstress-induced proteins are found in many trematodes and nema-
todes (Mazier and Mattei, 1991). HSP-70 is immunogenic in S.
mansoni-infected humans (Hedstrom et al., 1988) and is the target
of IgM and IgA responses in other trematode infections in mice
(Sotillo et al., 2008). Upregulation of heat shock proteins (HSPs)
in the earliest stages of intra-mammalian schistosomula develop-
ment is likely in response to the dramatic change in nichethesis. The tegument is renewed by the fusion of multilaminate vesicles trafficking
Jones et al., 2004). Proteome composition of the Schistosoma mansoni schistosomula
regulation, predicted function and/or previous published studies. DB, discoid bodies;
gen protein.
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freshwater and the human body; HSPs from nematodes that tran-
sition from free-living to parasitic stages are thought to function in
similar ways (Devaney, 2006).
The significantly regulated proteins were also classified accord-
ing to their predicted subcellular location and 67 of the 200 pro-
teins were predicted to be membrane-associated (Supplementary
Table S3). Several authors have placed emphasis on the apical
membrane proteins as vaccine candidates (Loukas et al., 2007;
McManus and Loukas, 2008; Pinheiro et al., 2011; Wilson, 2012).
The expression of Glucose transport protein-1 (SGTP1,
Smp_012440) and sterol reductase Lamin B receptor (ERG24,
Smp_124300) was upregulated in the tegument of schistosomula
over time. RNA interference (RNAi) suppression of S. mansoni
sgtp-1 expression decreased parasite survival by impairing parasite
feeding in S. mansoni schistosomula and adult worms (Krautz-
Peterson et al., 2010); moreover, sterols and fatty acids have been
proposed to be a good target for anti-schistosome interventions
(Parker-Manuel et al., 2011) due to the inability of the parasite to
de novo synthesise these molecules (Brouwers et al., 1997;
Berriman et al., 2009). Strikingly, the expression of some mem-
brane-associated proteins that have been proposed as vaccine anti-
gens in different Schistosoma spp., e.g. calpain (Ohta et al., 2004),
Na+/K+ atpase (Ohta et al., 2004; Yu et al., 2007; Da’dara et al.,
2013) and succinate dehydrogenase iron-sulfur protein (Yu et al.,
2007) were downregulated during schistosomula development. It
is also noteworthy that these proteins were also downregulated
over time in the underlying tissues (unbound sample) after tegu-
ment removal. The mechanisms of action of these subunit vaccines
are not yet fully understood, but their expression profiles and api-
cal tegument membrane location imply key roles in early migra-
tion of the parasite and maintenance of tegument integrity and/
or turnover.
Two distinct Venom Allergen-Like proteins - VAL-4
(Smp_002070) and VAL-6 (Smp_124050) were downregulated on
the maturing schistosomula tegument compared with newly
transformed schistosomula. Other members of the VAL family
(VAL-10, VAL-16) were also downregulated in the unbound sam-
ple. Downregulated expression of val genes (val-4 and val-16) has
also been reported in schistosomula compared with expression
levels in cercariae and germ balls (Parker-Manuel et al., 2011),
and val-6 expression is upregulated in both cercariae and adult
worms (Rofatto et al., 2012). These changes in val gene and corre-
sponding protein expression imply distinct functions for these pro-
teins in different aspects of host–parasite biology, including
cercarial matrix development and penetration, snail invasion by
miracidia, and intra-molluscan sporocyst development (Yoshino
et al., 2014). This family of proteins is abundant in different hel-
minth species including gastrointestinal nematodes, where they
play various roles in the infective process of parasitic species
(Hawdon et al., 1999; Cantacessi et al., 2009; Tribolet et al.,
2015). They have been trialed as vaccines against hookworm infec-
tion in humans (Diemert et al., 2012), and should be considered as
potential vaccine antigens for schistosomiasis.
Tetraspanins (TSPs) are a family of transmembrane proteins
that have shown efficacy in small and large animal models of schis-
tosomiasis (Loukas et al., 2007), and were detected in biotinylated
and unbound tegument tissues. Sm-TSP-2 is essential for tegument
formation (Tran et al., 2010) and is a target of protective immunity
in vaccinated mice and naturally resistant human subjects (Tran
et al., 2006). Sm-TSP-1 was found on the apical membrane of schis-
tosomula, although its expression levels were not significantly reg-
ulated throughout the experiment; Sm-TSP-2 on the other hand
was only found in the unbound sample, which agrees with previ-
ous findings showing localisation within internal compartments
associated with surface invaginations and vesicles in the tegument(Schulte et al., 2013), but is in contrast with other studies that
show Sm-TSP-2 on the surface of live 5 day old schistosomula
when probed with anti-Sm-TSP-2 antiserum (Tran et al., 2010).
Other protective vaccine antigens including GST and several
annexins were found upregulated on the apical membrane during
schistosomula growth. Annexins have been speculated to ‘‘glue’’
the membranocalyx to the plasma membrane (Braschi and
Wilson, 2006), and GST appears to play a central role in the para-
site detoxification system (Smith et al., 1986). GST and other
antioxidant proteins might play an important role during schisto-
somula migration, and additional proteins with Redoxin and
Thioredoxin-like domains were upregulated at 5 days post-
transformation.
The tegument of S. mansoni is a very dynamic structure whose
composition is renewed constantly. The number of membrane-as-
sociated or cytoplasmic/nuclear proteins uniquely upregulated at
the different time points supports the notion of a continuous tegu-
ment turnover (Skelly and Shoemaker, 1996, 2001; Skelly and Alan
Wilson, 2006), so the identification of key proteins from the apical
membrane of schistosomula at the different stages of development
is crucial for understanding the biology and potential Achilles heel
of the parasite (Fig. 5). Herein we have combined membrane-la-
belling techniques with state-of-the-art quantitative proteomics
to identify tegumental proteins that could be important for the
development of new vaccine and drug targets against
schistosomiasis.
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